- Home
- LICN vs PRFX Comparison
LICN vs PRFX Comparison
Compare LICN & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- PRFX
- Stock Information
- Founded
- LICN 2004
- PRFX 2007
- Country
- LICN China
- PRFX Israel
- Employees
- LICN N/A
- PRFX N/A
- Industry
- LICN
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- LICN
- PRFX Health Care
- Exchange
- LICN Nasdaq
- PRFX Nasdaq
- Market Cap
- LICN 3.1M
- PRFX 2.9M
- IPO Year
- LICN 2023
- PRFX 2020
- Fundamental
- Price
- LICN $4.44
- PRFX $1.38
- Analyst Decision
- LICN
- PRFX Hold
- Analyst Count
- LICN 0
- PRFX 1
- Target Price
- LICN N/A
- PRFX N/A
- AVG Volume (30 Days)
- LICN 22.6K
- PRFX 322.4K
- Earning Date
- LICN 01-01-0001
- PRFX 08-14-2025
- Dividend Yield
- LICN N/A
- PRFX N/A
- EPS Growth
- LICN N/A
- PRFX N/A
- EPS
- LICN N/A
- PRFX N/A
- Revenue
- LICN $41,477,000.00
- PRFX N/A
- Revenue This Year
- LICN N/A
- PRFX N/A
- Revenue Next Year
- LICN N/A
- PRFX N/A
- P/E Ratio
- LICN N/A
- PRFX N/A
- Revenue Growth
- LICN 4.32
- PRFX N/A
- 52 Week Low
- LICN $2.60
- PRFX $1.25
- 52 Week High
- LICN $488.00
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- LICN 53.94
- PRFX 35.23
- Support Level
- LICN $4.02
- PRFX $1.25
- Resistance Level
- LICN $4.41
- PRFX $1.48
- Average True Range (ATR)
- LICN 0.25
- PRFX 0.11
- MACD
- LICN 0.05
- PRFX 0.00
- Stochastic Oscillator
- LICN 92.57
- PRFX 29.53
About LICN Lichen China Limited
Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.